Scilex Holding Company Notes Issued
Scilex Holding Company (SCLX) reported Notes Issued of $24.00 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NotesIssued1 · last filed 2023-11-14
- Scilex Holding Company notes issued for the quarter ending 2023-09-30 was $0.00.
- Scilex Holding Company notes issued for the quarter ending 2021-03-31 was $125.00K.
| Period end | Notes Issued 3 month | Notes Issued 6 month | Notes Issued 9 month | Notes Issued 10 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $24.00M 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | $24.00M 10-Q · filed 2023-08-11 | |||
| 2021-03-31 | $125.00K 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $25.00K 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |